Sep 16
Current report
8-K/A
Regulation FD disclosure
CNSP · CNS Pharmaceuticals, Inc. · Documents
Market Cap
$5.29M
Shares
1.46M
Volume · Nov 12
2870
Avg daily vol (3M)
9663
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2020
Sep 16
Current report
8-K
Regulation FD disclosure
Sep 4
Current report
8-K
Events of Sep 1
Director or officer change, or executive pay
Aug 10
Jun 25
Current report
8-K
Regulation FD disclosure
Jun 11
Current report
8-K
Other events
Jun 9
Current report
8-K
Events of Jun 8
Shareholder vote results
May 28
Current report
8-K
Other events
May 27
Current report
8-K
Other events
May 18
Current report
8-K
Other events
May 15
Apr 24
Proxy statement
DEF 14A
Meeting May 7, 2020
Proxy statement
Mar 26
Current report
8-K
Events of Mar 20
Entered into a material agreement
Mar 12
Current report
8-K
Financial results
Mar 12
Mar 10
Current report
8-K
Regulation FD disclosure
Mar 2
Current report
8-K
Regulation FD disclosure
Jan 16
Current report
8-K
Events of Jan 15
Regulation FD disclosure
Jan 16
Current report
8-K
Events of Jan 10
Entered into a material agreement, Regulation FD disclosure
Jan 13
Current report
8-K
Regulation FD disclosure
Showing 151–170 of 170 documents